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Abstract
Background: Consanguinity is an important risk factor for autosomal recessive (AR) disorders. Extended genomic
regions identical by descent (IBD) in the offspring of consanguineous parents give rise to recessive disorders with
identical (homozygous) pathogenic variants in both alleles. However, many clinical phenotypes presenting in the
offspring of consanguineous couples are still of unknown etiology. Nowadays advances in High Throughput
Sequencing provide an excellent opportunity to achieve a molecular diagnosis or to identify novel candidate genes.
Results: To exploit all available information from the family structure we developed CATCH, an algorithm that
combines genotyped SNPs of all family members for the optimal detection of Runs Of Homozygosity (ROH) and
exome sequencing data from one affected individual to identify putative causative variants in consanguineous families.
Conclusions: CATCH proved to be effective in discovering known or putative new causative variants in 43 out of 50
consanguineous families. Among them, novel variants causative of familial thrombocytopenia, sclerosis bone dysplasia
and the first homozygous loss-of-function mutation in FGFR3 in human causing severe skeletal deformities, tall stature
and hearing impairment were identified.
Background
The investigation of the molecular basis of monogenic dis-
orders has succeeded in identifying thousands of patho-
genic variants in protein-coding genes that cause these
disorders. There are, however, thousands of additional
(near) Mendelian phenotypes for which the molecular
genetics is still unknown. Indeed, the rarity of many such
disorders, the lack of statistical power due to the non-
availability of large families, locus heterogeneity, and
the limitations of sequencing technologies hindered the
search for “Mendelian” pathogenic variants. Neverthe-
less, extended genomic regions identical by descent
(IBD) in the offspring of consanguineous mattings give
rise to recessive disorders with identical (homozygous)
pathogenic variants in both alleles. Consanguinity is
practiced in a large proportion of human populations;
rates reach 20-50 % in much of the Mediterranean basin
[1]. Therefore, in a consanguineous family, the search for
the unknown causative gene is magnified. The typical
two-step approach is to first identify extended genomic
homozygous regions (ROH, Runs of Homozygosity) by
genotyping all available family members with SNP arrays.
Putative candidate regions are then the ROHs that are
shared among all affected individuals. Second, the causa-
tive variant is finally discovered by Sanger sequencing the
genes inside the candidate regions. Nowadays this slow
and laborious task may be conveniently relieved by Whole
Exome Sequencing (WES) of one of the affected. Indeed, it
has recently been shown that combining SNP arrays and
WES data is a successful approach to the identification of
causative variants in homozygosity [2]. Some attempts have
been made on the extraction of ROH from WES data only,
but the accuracy of these methods has proven to be sub-
optimal with respect of the usage of SNP arrays [3]. In the
future, Whole Genome Sequencing (WGS) will provide at
the same time the variants with a more accurate ROH esti-
mation than WES based approaches but, at the moment,
this procedure is far from being cost-effective.
In order to integrate WES sensitivity with the optimal
delineation of ROHs by SNP arrays in a comprehensive
computational tool, we developed CATCH (Consanguinity
Analysis Through Common Homozygosity). The algo-
rithm recognizes affected specific ROHs from SNP array
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data and, inside these selected ROHs, identifies putative
candidate genes from the integration of exome sequenced




CATCH takes as input: 1) the variants packaged in
the standard Variant Calling Format (VCF) for one
affected individual of the family; 2) a PED formatted
file (http://pngu.mgh.harvard.edu/~purcell/plink/) describ-
ing the pedigree structure and the genotypes of all inform-
ative members of the family; and 3) ROH (Runs Of
Homozygosity) regions as calculated by PLINK from
the PED file and SNP arrays data. In this study, we used
the HumanOmniExpress Bead Chip by IlluminaInc®
(San Diego, CA) to genotype all family members. This
SNP array tests 720 K SNPs with a mean distance of
4 kb between the SNPs. We defined as homozygous re-
gions those regions with 50 consecutive homozygous
SNPs. Exome was captured using SureSelect Human
All Exons. Sequencing was performed with the Illumina
HiSeq2000 and row reads were aligned with BWA [4].
Variant calling has been performed with SAMtools [5]
and Pindel [6].
Data processing
CATCH makes use of Annovar [7] to annotate sequenced
variants. After, it discards non-splicing or non-exonic, syn-
onymous, heterozygous and frequent variants in the
general population (variant with MAF < 2 % in 1000
Genomes are retained [www.1000genomes.org; the results
presented here have been obtained with April 2012
release]). Furthermore, CATCH does not consider vari-
ants that are in duplicated regions or exceedingly strand
biased (i.e., 0 reads in one strand of the alternative allele).
For each selected variant found in the genome of the
sequenced (affected) individual, CATCH fetches for the
related ROH and calculates the overlap with the ROHs of
the other affected family members (if available) and the
intersection with the respective ROH of all remaining un-
affected individuals of the family. If an overlap is found, in
order to exclude that the regions are identical by state
(IBS), CATCH additionally considers the SNPs in the
ROH surrounding the variant and evaluates the eventual
concordance with the haplotypes of all family members
allowing for 1 % mismatch (Fig. 1). An important excep-
tion is when the ROH of the unaffected is smaller than
the overlapping ROH of the affected. In this case affected
and unaffected individuals may be identical by state (IBS)
for that haplotype block but the origin of the haplotype is
actually different. In general the haplotype size depends
on age, smaller being older and younger being longer [8].
Therefore, long and younger haplotypes could include a
recent, deleterious variant that can be transmitted to the
affected individuals along with its entire haplotype block
in homozygosity through the imbreeding loops [9].
Unaffected individuals may inherit one copy of this haplo-
type and one copy of the older one, thus being IBS for the
smaller haplotype. We found an example of such a variant
in the gene VLDLR [10].
In summary, each variant in homozygosity is assigned
to one of the following classes:
1. Class1 (Putative): neither overlap with ROH regions
nor IBD has been detected with unaffected
individuals.
2. Class2 (Common): IBD with some unaffected
individual has been detected.
3. Class3 (Inside): ROH of the affected is longer than
the overlapping ROH of the unaffected (IBS).
The output is provided as a comma separated plain
text containing the annotated variants and the class they
have been assigned by CATCH.
Ethics approval
The study was approved by the Bioethics Committee of
the University Hospitals of Geneva (Protocol number:
CER 11–036).
Results
As its first application, CATCH has been employed on
processed samples collected from 50 consanguineous fam-
ilies suggestive of AR of inheritance and a wide spectrum
of AR phenotypes [10]. Briefly, all samples were genotyped
with a dense SNP array (HumanOmniExpress Bead Chip
by Illumina) to identify Runs of Homozygosity and exome
sequencing on the Illumina HiSeq2000 was performed on
one affected individual per family. Prior to CATCH, raw
fastq files have been processed through a custom pipeline
composed by BWA [4], samtools [5] rmdup and (i) sam-
tools mpileup for the detection of Single Nucleotide Vari-
ants (SNV) (ii) Pindel [6] for the detection of insertions
and deletions. All tools were run with default parameters.
On average, 21,719 variants were identified per patient.
ROHs were calculated by PLINK as stretches of 50 homo-
zygous consecutive SNPs irrespective of the total length of
the genomic region, allowing for one mismatch. We con-
sidered this as a reasonable trade-off between catching a
significant amount of ROH (Additional file 1: Figure S1)
and limiting the number of small IBS regions that are
common in all individuals. Only relatively frequent
SNPs (MAF >0.3) were included in the analysis. The
ROH were further defined as genomic regions demar-
cated by the first encountered heterozygous SNPs
flanking each established homozygous region. The vari-
ants that CATCH reported as belonging to Class 1
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(Putative) or Class 3 (Inside) were ranked according to
the following criteria:
1) pathogenic variants: known pathogenic variant or
variant in known pathogenic gene according to the
phenotype; 2) strong candidates variants: variant in a
gene likely involved in the pathology according to support-
ing literature data; 3) Variant of Unknown Significance -
VUS: variant predicted to be pathogenic but in a gene not
known to be related to the phenotype (Additional file 1:
Figure S1). For strong candidate variants, we combined in-
formation about any known function of the gene and the
gene’s family, data coming from animal models or other in
vitro experiments and tissue expression. Functional
validation and further investigations of the clinical rele-
vance of these variants are still ongoing.
In 18 families, CATCH clearly identified the pathogenic
variant in known disease-causing genes (Class 1 -DMP1,
ARFGEF, FKTN, SEPSECS, GUCY2D, BBS4, SYNE1,
POMGNT, MTFMT, TACO1, PYGM, PRX, TUSC3,
STRA6, ALDH3A2, RNASET2, MMP2 and Class 3 -
VLDLR). Detailed information about the variants are re-
ported in (Additional file 2: Table S1). In 5 families, strong
candidates were identified in genes functionally related to
the phenotype and, in a further 22 families, variants of
predicted pathogenicity according to by SIFT [11], Poly-
Phen [12] and Mutation Taster [13] were labeled as VUS.
In 5 families, no reasonable candidates or VUS were iden-
tified. All discovered variants and the predicted segrega-
tions were further validated with conventional sequencing.
Eventually, CATCH suggested at least one causative
Fig. 1 Schematic showing CATCH strategy for the identification of putative causative variants. Variants provided by a standard variant calling
pipeline (i.e. BWA + Samtools or GATK ) are annotated by Annovar and filtered according to user preferences. ROH are calculated from SNPArray
data by Plink for all available affected and unaffected family members. CATCH classifies every variant according to its presence/absence in ROHs
as depicted in the figure. Green and red areas represent affected (A) and unaffected (U) ROH respectively
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variant in 36 % of families which represents a substantial
improvement in the ability to diagnose recessively inher-
ited disorders in consanguineous families [14].
In three additional studies CATCH discovered the
causative variants associated to three different genetic
diseases.
– A highly consanguineous family from Northern Iraq
presented in several members with familial
thrombocytopenia with small size platelets. CATCH
identified one homozygous pathogenic variant in
FYB [15], a gene encoding for a cytosolic adaptor
molecule expressed by T, natural killer (NK),
myeloid cells and platelets, and involved in platelet
activation and controls the expression of
interleukin-2. Knock-out mice were reported to
show isolated thrombocytopenia.
– Two sisters from a consanguineous Lebanese family
were previously reported as presenting a new
atypical form of sclerosing bone dysplasia [16].
CATCH identifies a potential causative variant in
the gene DMP1, a transcriptional activator of
osteoblast-specific genes such as alkaline phosphatase
and osteocalcin [17], already associated to Autosomal
Recessive Hypophosphatemic Rickets (ARHR) [18].
The variant causes the loss of a highly conserved
signal sequence of 16 amino acids resulting in a
complete absence of the excretion of the protein and
its retention within the cells. The diagnosis was
accordingly corrected, demonstrating the importance
of this approach in the delineation of the molecular
basis of rare diseases especially when the clinical
presentation is unclear.
– Two affected brothers born to first cousin parents
originating from Egypt presented with severe skeletal
deformities, tall stature and hearing impairment.
CATCH identified the first homozygous loss-of-
function (predicted) mutation in FGFR3 in human
[19]. This gene is one of many physiological regulators
of linear bone growth and normally functions as an
inhibitor, acting negatively on both proliferation and
terminal differentiation of growth plate chondrocytes
[20]. Before this finding, all pathogenic FGFR3
mutations in humans were associated with constitutive
FGFR3 activation by impairing endochondral bone
growth.
Conclusions
The use of whole exome sequencing in the detection of
causative variants in homozygosity is really effective
when associated to segregation data in a familiar con-
text. Highly consanguineous relatives share several long
Runs Of Homozygosity thus they bear a large number of
potential causative variants. Of course, additional exome
sequencing of non-affected relatives would dramatically
reduce the number of false positives. However, the same
result may be obtained at a considerably lower cost by
genotyping these individuals and restricting exome se-
quencing to only one affected patient. CATCH is the
first computational tool that process ROH, genotyping
and exome sequencing data in an integrated way. It is
handy and efficient, needing less than 5 min to analyze a
nuclear family after annotation. It is written in Python
and can run on a standard computer with a reasonable
amount of RAM (>1GB). CATCH is released as Linux
executable.
Availability of the software
 Project name: CATCH
 Project home page: http://seaseq.unige.ch/~fsantoni/
CATCH
 Operating system(s): Linux
 Programming language: Python
 Other requirements: Python 2.6 or higher
 License: GNU GPL.
 Any restrictions to use by non-academics: license
needed
Consent to publish
All patients and/or parents provided their written in-
formed consent for the analyses performed and for the
publication of the results.
Availability of supporting data
All the variants mentioned in this study have been submitted
to LOVD (http://databases.lovd.nl/whole_genome/genes).
Additional files
Additional file 1: Figure S1. Flow chart diagram explaining the process
of identification and ranking of putative candidate variants. After
assignment of the pathogenicity scores according to SIFT, PolyPhen (PP)
and MutationTaster (MT), CATCH classifies the variants according to ROHs
(see Fig. 1 and main text). Only Class I and Class III are further labeled as:
pathogenic - being a known pathogenic or a predicted pathogenic
variant inside a know pathogenic gene related to the phenotype; strong
candidate - predicted pathogenic variant in a gene likely involved in the
pathology according to supporting literature data; Variant of Unknown
significance (VUS) - predicted pathogenic variant in a gene not known to
be related to the phenotype; − Benign - predicted non pathogenic
variants not reported as causative in the literature. (DOCX 56 kb)
Additional file 2: Table S1. Class I pathogenic variants in known
disease-causing genes identified in 17 consanguinous families. (DOCX 15
kb)
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